OBJECTIVE: HIV has been associated with increased risks of certain kinds of malignancies. Cancer of the cervix is quite common in our environment and has been classified as an AIDS-defining malignancy in some countries. The objective of our study is to determine the prevalence of HIV sero-prevalence among patients attending our clinics with histologically confirmed Cancer of the Cervix. METHODS: All records of patients diagnosed with histologically confirmed Cancer of the Cervix in our clinic over a three-year period (2005 - 2007) were reviewed. Details included HIV status of the patients. Results were analyzed to determine the sero-prevalence of HIV among the patients RESULTS: 221 patients were seen during the period with age ranged between 29 and 85 years with a mean value of 55.08. More than 80% of the patients had disease stages of 2b and above. Only 6 patients (2.7%) were positive. The rest were negative. CONCLUSION: The prevalence of HIV among patients with cancer of the cervix in our clinic is low compared to results from some other places in Africa.
OBJECTIVE: HIV has been associated with increased risks of certain kinds of malignancies. Cancer of the cervix is quite common in our environment and has been classified as an AIDS-defining malignancy in some countries. The objective of our study is to determine the prevalence of HIV sero-prevalence among patients attending our clinics with histologically confirmed Cancer of the Cervix. METHODS: All records of patients diagnosed with histologically confirmed Cancer of the Cervix in our clinic over a three-year period (2005 - 2007) were reviewed. Details included HIV status of the patients. Results were analyzed to determine the sero-prevalence of HIV among the patients RESULTS: 221 patients were seen during the period with age ranged between 29 and 85 years with a mean value of 55.08. More than 80% of the patients had disease stages of 2b and above. Only 6 patients (2.7%) were positive. The rest were negative. CONCLUSION: The prevalence of HIV among patients with cancer of the cervix in our clinic is low compared to results from some other places in Africa.
Authors: F Sitas; R Pacella-Norman; H Carrara; M Patel; P Ruff; R Sur; U Jentsch; M Hale; P Rowji; D Saffer; M Connor; D Bull; R Newton; V Beral Journal: Int J Cancer Date: 2000-11-01 Impact factor: 7.396
Authors: J M Palefsky; H Minkoff; L A Kalish; A Levine; H S Sacks; P Garcia; M Young; S Melnick; P Miotti; R Burk Journal: J Natl Cancer Inst Date: 1999-02-03 Impact factor: 13.506
Authors: Sally N Akarolo-Anthony; Luigino Dal Maso; Festus Igbinoba; Sam M Mbulaiteye; Clement A Adebamowo Journal: Infect Agent Cancer Date: 2014-03-05 Impact factor: 2.965